Hostname: page-component-77c89778f8-m8s7h Total loading time: 0 Render date: 2024-07-18T06:41:38.273Z Has data issue: false hasContentIssue false
  • English
  • Français

Immunoglobulin allotypes Gm and Km in chronic schizophrenia: no apparent association

Published online by Cambridge University Press:  09 July 2009

David N. Propert
David N. Propert*
Affiliation:
Department of Psychiatry, University of Melbourne, Parkville, Victoria, Australia
*
1Address for correspondence: Dr David Propert, Department of Applied Biology, Royal Melbourne Institute of Technology, 124 La Trobe Street, Melbourne, Victoria 3000, Australia.
Get access Rights & Permissions [Opens in a new window]

Synopsis

The distribution of the immunoglobulin allotypic markers G1m(1), G1m(2), G1m(3), G3m(5) and Km(1) was determined in 168 hospitalized Caucasian chronic schizophrenic patients and compared with that in healthy controls. No association between Gm or Km phenotypes and chronic schizophrenia is apparent.

Type
Research Article
Information
Psychological Medicine , Volume 13 , Issue 1 , February 1983 , pp. 27 - 30
Copyright
Copyright © Cambridge University Press 1983

Access options

Get access to the full version of this content by using one of the access options below. (Log in options will check for institutional or personal access. Content may require purchase if you do not have access.)

References

American Psychiatric Association (1980). Diagnostic and Statistical Manual of Mental Disorders(third edition). APA: Washington, D.C.Google Scholar
Amkraut, A., Solomon, G. F., Allansmith, M., McClellan, B. & Rappaport, M. (1973). Immunoglobulins and improvement in acute schizophrenic reactions. Archives of General Psychiatry 28, 673–677.CrossRefGoogle ScholarPubMed
Bergen, J. R., Grinspoon, L., Pyle, H. M., Martinez, J. L. & Pennell, R. B. (1980). Immunologic studies in schizophrenic and control subjects. Biological Psychiatry 15, 369–379.Google ScholarPubMed
Bleuler, M. (1978). The Schizophrenic Disorders. Yale University Press: New Haven.Google Scholar
Brachtel, R., Walter, H., Beck, W. & Hilling, M. (1979). Associations between atopic diseases and the polymorphic systems ABO, Kidd, Inv and red cell acid phosphatase. Human Genetics 49, 337–348.CrossRefGoogle ScholarPubMed
Brackenridge, C. J. & Jones, I. H. (1968). The effect of neuroleptic drug treatment on plasma fibrinogen concentrations in schizophrenic states. Journal of Neurology, Neurosurgery and Psychiatry 31, 326–329.CrossRefGoogle ScholarPubMed
Brackenridge, C. J. & Jones, I. H. (1972). Group-specific component and haptoglobin distributions in schizophrenic States. Clinical Genetics 3, 325–333.CrossRefGoogle ScholarPubMed
Elston, R. C., Kringlen, E. & Namboodiri, K. K. (1973). Possible linkage relationships between certain blood groups and schizophrenia or other psychoses. Behavior Genetics 3, 101–106.CrossRefGoogle ScholarPubMed
Farid, N. R., Newton, R. M., Noel, E. P. & Marshall, W. H. (1977). Gm phenotypes in autoimmune thyroid disease. Journal of Immunogenetics 4, 429–432.CrossRefGoogle ScholarPubMed
Fontana, A., Storck, U., Angst, J., Dubs, R., Abegg, A. & Grob, P. J. (1980). An immunological basis of schizophrenia and affective disorders? Neuropsychobiology 6, 284–289.CrossRefGoogle ScholarPubMed
Gowdy, J. M. (1980). Immunoglobulin levels in psychotic patients. Psychosomatics 21, 751–756.CrossRefGoogle ScholarPubMed
Kuritzky, A., Livni, E., Munitz, H., Englander, T., Tyano, S., Wijsenbeek, H., Joshua, H. & Kott, E. (1976). Cell-mediated immunity to human myelin basic protein in schizophrenic patients. Journal of the Neurological Sciences 30, 369–373.CrossRefGoogle ScholarPubMed
Luchins, D., Torrey, E. F., Weinberger, D. R., Zalcman, S., Delisi, L., Johnson, A., Rogentine, N. & Wyatt, R. J. (1980). HLA antigens in schizophrenia: differences between patients with and without evidence of brain atrophy. British Journal of Psychiatry 136, 243–248.CrossRefGoogle ScholarPubMed
McGuffin, P. (1979). Is schizophrenia an HLA-associated disease? Psychological Medicine 9, 721–728.CrossRefGoogle ScholarPubMed
Mentnech, M. S., Pearson, D. J., Elliott, J. A., Taylor, G. & Major, P. C. (1980). Correlation of Gm allotype with the incidence of anti-IgG antibody in coal workers' pneumoconiosis. Clinical Immunology and Immunopathology 17, 274–279.CrossRefGoogle Scholar
Morell, A., Skvaril, F., Steinberg, A. G., van Loghem, E. & Terry, W. D. (1972). Correlations between the concentrations of the four subclasses of IgG and Gm allotypes in normal human sera. Journal of Immunology 108, 195–206.CrossRefGoogle ScholarPubMed
Nakao, Y., Matsumoto, H., Miyazaki, T., Nishitani, H., Ota, K., Fujita, T. & Tsuji, K. (1980 a). Gm allotypes in myasthenia gravis. Lancet i, 677–680.CrossRefGoogle Scholar
Nakao, Y., Matsumoto, H., Miyazaki, T., Nishitani, H., Takatsuki, K., Kasukawa, R., Nakayama, S., Izumi, S., Fujita, T. & Tsuji, K. (1980 b). IgG heavy chain allotypes (Gm) in autoimmune diseases. Clinical and Experimental Immunology 42, 20–26.Google ScholarPubMed
Nakao, Y., Matsumoto, H., Miyazaki, T., Mizuno, N., Arima, N., Wakisaka, A., Okimoto, K., Akazawa, Y., Tsuji, K. & Fujita, T. (1981). IgG heavy-chain (Gm) allotypes and immune response to insulin in insulin-requiring diabetes mellitus. New England Journal of Medicine 304, 407–409.CrossRefGoogle ScholarPubMed
Pandey, J. P., Fudenberg, H. H., Virella, G., Kyong, C. U., Loadholt, C. B., Galbraith, R. M., Gotschlich, E. C. & Parke, J. C. (1979). Association between immunoglobulin allotypes and immune responses to Haemophilus influenzae and meningococcus polysaccharides. Lancet i, 190–192.CrossRefGoogle Scholar
Pandey, J. P., Goust, J. M., Salier, J. P. & Fudenberg, H. H. (1981). Immunoglobulin G heavy chain (Gm) allotypes in multiple sclerosis. Journal of Clinical Investigation 67, 1797–1800.CrossRefGoogle ScholarPubMed
Propert, D. N., Bernard, C. C. A. & Simons, M. J. (1982). Gm allotypes and multiple sclerosis. Journal of Immunogenetics 9 (In the press).Google ScholarPubMed
Pulkkinen, E. (1977). Immunoglobulins, psychopathology and prognosis in schizophrenia. Acta Psychiatrica Scandinavica 56, 173–182.CrossRefGoogle ScholarPubMed
Roberts, D. F. & Kinnell, H. G. (1981). Immunogenetics and schizophrenia. Psychological Medicine 11, 441–447.CrossRefGoogle ScholarPubMed
Steinberg, A. G. & Cook, C. E. (1981). The Distribution of the Human Immunoglobulin Allotypes. Oxford University Press: Oxford.Google Scholar
Strahilevitz, M., Fleischman, J. B., Fischer, G. W., Harris, R. & Narasimhachari, N. (1976). Immunoglobulin levels in psychiatric patients. American Journal of Psychiatry 133, 772–777.Google ScholarPubMed
Uno, H., Sasazuki, T., Tamai, H. & Matsumoto, H. (1981). Two major genes, linked to HLA and Gm, control susceptibility to Graves' disease. Nature 292, 768–770.CrossRefGoogle ScholarPubMed
Walzer, P. D. & Kunkel, H. G. (1974). The correlation of serum IgD concentration with Gm allotype. Journal of Immunology 113, 274–278.CrossRefGoogle ScholarPubMed
Wells, J. V., Fudenberg, H. H. & Mackay, I. R. (1971). Relation of the human antibody response to flagellin to Gm genotype. Journal of Immunology 107, 1505–1511.CrossRefGoogle ScholarPubMed
Whittingham, S., Mathews, J. D., Schanfield, M. S., Matthews, J. V., Tait, B. D., Morris, P. J. & Mackay, I. R. (1980). Interactive effect of Gm allotypes and HLA-B locus antigens on the human antibody response to a bacterial antigen. Clinical and Experimental Immunology 40, 8–15.Google ScholarPubMed
Whittingham, S., Mathews, J. D., Schanfield, M. S., Tait, B. D. & Mackay, I. R. (1981). Interaction of HLA and Gm in autoimmune chronic active hepatitis. Clinical and Experimental Immunology 43, 80–86.Google ScholarPubMed
World Health Organization (1978). International Classification of Diseases (ninth revision) WHO: Geneva.Google Scholar